Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

The global burden of cardiovascular disease morbidity and mortality demands increased
awareness of effective prevention strategies by patients, communities and health-care …

Summary of the Clinical Problem Atherosclerotic cardiovascular disease (ASCVD) remains
the leading cause of death in the United States. Most individuals who develop ASCVD have …

Cardiovascular disease remains a substantial concern in terms of global mortality and
morbidity, while prevalence of cardiovascular disease is increasing as treatment modalities …

Prevention of cardiovascular disease, undoubtedly an emphasis of clinical care in 2014, will
provide both opportunities and challenges to patients and their healthcare providers. The …

Abstract Purpose of Review Summarize selected late-breaking science on cardiovascular
(CV) disease prevention presented at the 2022 scientific session of the American Heart …

With the changing demography of populations and increasing prevalence of co-morbidity,
frail patients and more complex cardiac conditions, the modern medicine is facing novel …

Prevention of cardiovascular diseases (CVDs), particularly atherosclerosis, remains a
priority on the global health agenda. A healthy lifestyle at both individual and population …

Abstract Purpose of Review This review intends to highlight selected cardiovascular disease
(CVD) prevention studies presented at the 2019 European Society of Cardiology (ESC) …

Cardiovascular disease (CVD) is the most important cause of premature death and disability
globally. Much is known of the main aetiological risk factors, including elevated blood …